We partner with international pharmaceutical companies to act as Swiss marketing authorization holder (MAH) and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced, have a long history of success and provide indepth expertise of commercial operations in therapeutic domains such as oncology and rare diseases.
